These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27144735)

  • 1. Disease models for the development of therapies for lysosomal storage diseases.
    Xu M; Motabar O; Ferrer M; Marugan JJ; Zheng W; Ottinger EA
    Ann N Y Acad Sci; 2016 May; 1371(1):15-29. PubMed ID: 27144735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of induced pluripotent stem cells in lysosomal storage diseases.
    Kido J; Nakamura K; Era T
    Mol Cell Neurosci; 2020 Oct; 108():103540. PubMed ID: 32828964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.
    Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P
    Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Therapies for Lysosomal Storage Diseases.
    Gabig-Cimińska M; Jakóbkiewicz-Banecka J; Malinowska M; Kloska A; Piotrowska E; Chmielarz I; Moskot M; Węgrzyn A; Węgrzyn G
    Curr Mol Med; 2015; 15(8):746-71. PubMed ID: 26391547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal storage diseases--the horizon expands.
    Boustany RM
    Nat Rev Neurol; 2013 Oct; 9(10):583-98. PubMed ID: 23938739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.
    Seregin SS; Amalfitano A
    Curr Pharm Des; 2011; 17(24):2558-74. PubMed ID: 21774776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving therapies in neuronopathic LSDs: opportunities and challenges.
    Rajan DS; Escolar ML
    Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for lysosomal storage diseases (LSDs) in large animal models.
    Haskins M
    ILAR J; 2009; 50(2):112-21. PubMed ID: 19293456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of gene therapy in canine and feline models of lysosomal storage disorders.
    Bradbury AM; Gurda BL; Casal ML; Ponder KP; Vite CH; Haskins ME
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):27-37. PubMed ID: 25671613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases.
    Huang HP; Chuang CY; Kuo HC
    Stem Cell Res Ther; 2012 Aug; 3(4):34. PubMed ID: 22925465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells.
    Sabitha KR; Chandran D; Shetty AK; Upadhya D
    Stem Cells Dev; 2022 May; 31(9-10):221-238. PubMed ID: 35316126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNX8 enables lysosome reformation and reverses lysosomal storage disorder.
    Li X; Xiang C; Zhu S; Guo J; Liu C; Wang A; Cao J; Lu Y; Neculai D; Xu P; Feng XH
    Nat Commun; 2024 Mar; 15(1):2553. PubMed ID: 38519472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Lysosomal Storage Diseases to NKT Cell Activation and Back.
    Pereira CS; Ribeiro H; Macedo MF
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for lysosomal storage diseases: the lessons and promise of animal models.
    Ellinwood NM; Vite CH; Haskins ME
    J Gene Med; 2004 May; 6(5):481-506. PubMed ID: 15133760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for lysosomal storage disorders: a good start.
    Biffi A
    Hum Mol Genet; 2016 Apr; 25(R1):R65-75. PubMed ID: 26604151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.